+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Emergency Contraceptive Pills Market 2024-2028

  • PDF Icon

    Report

  • 162 Pages
  • May 2024
  • Region: Global
  • TechNavio
  • ID: 5449062
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The emergency contraceptive pills market is forecast to grow by USD 240.3 million during 2023-2028, accelerating at a CAGR of 4.36% during the forecast period. The report on the emergency contraceptive pills market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rise in number of initiatives to create awareness, increase in unplanned pregnancies, and ease of online purchase.

The emergency contraceptive pills market is segmented as below:

By Distribution Channel

  • Retail stores
  • Online stores

By Type

  • Combination pills
  • Progesterone pills

By Geography

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the importance of family planning as one of the prime reasons driving the emergency contraceptive pills market growth during the next few years. Also, advent of online apps and rising disposable income will lead to sizable demand in the market.

The report on the emergency contraceptive pills market covers the following areas:

  • Emergency contraceptive pills market sizing
  • Emergency contraceptive pills market forecast
  • Emergency contraceptive pills market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading emergency contraceptive pills market vendors that include AbbVie Inc., Afaxys Pharma LLC, Bayer AG, Combe Inc., Foundation Consumer Healthcare LLC, Gedeon Richter Plc, HLL Lifecare Ltd., Knoll Healthcare Pvt. Ltd., Laboratoire HRA Pharma SAS, Lupin Ltd., Mankind Pharma Ltd., Morepen Laboratories Ltd., Perrigo Co. Plc, Pfizer Inc., Piramal Enterprises Ltd., Sun Pharmaceutical Industries Ltd., Syzygy Healthcare LLC, and Teva Pharmaceutical Industries Ltd.. Also, the emergency contraceptive pills market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market by Geography
Executive Summary - Chart on Market Segmentation by Distribution Channel
Executive Summary - Chart on Market Segmentation by Type
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning
2 Market Landscape
2.1 Market ecosystem
Parent Market
Data Table on - Parent Market
2.2 Market characteristics
Market characteristics analysis
2.3 Value chain analysis
Value Chain Analysis
3 Market Sizing
3.1 Market definition
Offerings of companies included in the market definition
3.2 Market segment analysis
Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Chart on Global - Market size and forecast 2023-2028 ($ million)
Data Table on Global - Market size and forecast 2023-2028 ($ million)
Chart on Global Market: Year-over-year growth 2023-2028 (%)
Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Global Emergency Contraceptive Pills Market 2018 - 2022
Historic Market Size - Data Table on Global Emergency Contraceptive Pills Market 2018 - 2022 ($ million)
4.2 Distribution Channel segment analysis 2018 - 2022
Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
4.3 Type segment analysis 2018 - 2022
Historic Market Size - Type Segment 2018 - 2022 ($ million)
4.4 Geography segment analysis 2018 - 2022
Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country segment analysis 2018 - 2022
Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Distribution Channel
6.1 Market segments
Chart on Distribution Channel - Market share 2023-2028 (%)
Data Table on Distribution Channel - Market share 2023-2028 (%)
6.2 Comparison by Distribution Channel
Chart on Comparison by Distribution Channel
Data Table on Comparison by Distribution Channel
6.3 Retail stores - Market size and forecast 2023-2028
Chart on Retail stores - Market size and forecast 2023-2028 ($ million)
Data Table on Retail stores - Market size and forecast 2023-2028 ($ million)
Chart on Retail stores - Year-over-year growth 2023-2028 (%)
Data Table on Retail stores - Year-over-year growth 2023-2028 (%)
6.4 Online stores - Market size and forecast 2023-2028
Chart on Online stores - Market size and forecast 2023-2028 ($ million)
Data Table on Online stores - Market size and forecast 2023-2028 ($ million)
Chart on Online stores - Year-over-year growth 2023-2028 (%)
Data Table on Online stores - Year-over-year growth 2023-2028 (%)
6.5 Market opportunity by Distribution Channel
Market opportunity by Distribution Channel ($ million)
Data Table on Market opportunity by Distribution Channel ($ million)
7 Market Segmentation by Type
7.1 Market segments
Chart on Type - Market share 2023-2028 (%)
Data Table on Type - Market share 2023-2028 (%)
7.2 Comparison by Type
Chart on Comparison by Type
Data Table on Comparison by Type
7.3 Combination pills - Market size and forecast 2023-2028
Chart on Combination pills - Market size and forecast 2023-2028 ($ million)
Data Table on Combination pills - Market size and forecast 2023-2028 ($ million)
Chart on Combination pills - Year-over-year growth 2023-2028 (%)
Data Table on Combination pills - Year-over-year growth 2023-2028 (%)
7.4 Progesterone pills - Market size and forecast 2023-2028
Chart on Progesterone pills - Market size and forecast 2023-2028 ($ million)
Data Table on Progesterone pills - Market size and forecast 2023-2028 ($ million)
Chart on Progesterone pills - Year-over-year growth 2023-2028 (%)
Data Table on Progesterone pills - Year-over-year growth 2023-2028 (%)
7.5 Market opportunity by Type
Market opportunity by Type ($ million)
Data Table on Market opportunity by Type ($ million)
8 Customer Landscape
8.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Chart on Market share By Geographical Landscape2023-2028 (%)
Data Table on Market share By Geographical Landscape2023-2028 (%)
9.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Chart on North America - Market size and forecast 2023-2028 ($ million)
Data Table on North America - Market size and forecast 2023-2028 ($ million)
Chart on North America - Year-over-year growth 2023-2028 (%)
Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Chart on Europe - Market size and forecast 2023-2028 ($ million)
Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Chart on Europe - Year-over-year growth 2023-2028 (%)
Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Chart on Asia - Market size and forecast 2023-2028 ($ million)
Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Chart on Asia - Year-over-year growth 2023-2028 (%)
Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Chart on US - Market size and forecast 2023-2028 ($ million)
Data Table on US - Market size and forecast 2023-2028 ($ million)
Chart on US - Year-over-year growth 2023-2028 (%)
Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 China - Market size and forecast 2023-2028
Chart on China - Market size and forecast 2023-2028 ($ million)
Data Table on China - Market size and forecast 2023-2028 ($ million)
Chart on China - Year-over-year growth 2023-2028 (%)
Data Table on China - Year-over-year growth 2023-2028 (%)
9.9 Germany - Market size and forecast 2023-2028
Chart on Germany - Market size and forecast 2023-2028 ($ million)
Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Chart on Germany - Year-over-year growth 2023-2028 (%)
Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.10 France - Market size and forecast 2023-2028
Chart on France - Market size and forecast 2023-2028 ($ million)
Data Table on France - Market size and forecast 2023-2028 ($ million)
Chart on France - Year-over-year growth 2023-2028 (%)
Data Table on France - Year-over-year growth 2023-2028 (%)
9.11 Japan - Market size and forecast 2023-2028
Chart on Japan - Market size and forecast 2023-2028 ($ million)
Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Chart on Japan - Year-over-year growth 2023-2028 (%)
Data Table on Japan - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity by geography
Market opportunity By Geographical Landscape($ million)
Data Tables on Market opportunity By Geographical Landscape($ million)
10 Drivers, Challenges, and Opportunity/Restraints
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Impact of drivers and challenges in 2023 and 2028
10.4 Market opportunities/restraints
11 Competitive Landscape
11.1 Overview
11.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
11.3 Landscape disruption
Overview on factors of disruption
11.4 Industry risks
Impact of key risks on business
12 Competitive Analysis
12.1 Companies profiled
Companies covered
12.2 Market positioning of companies
Matrix on companies position and classification
12.3 AbbVie Inc.
AbbVie Inc. - Overview
AbbVie Inc. - Product / Service
AbbVie Inc. - Key news
AbbVie Inc. - Key offerings
12.4 Afaxys Pharma LLC
Afaxys Pharma LLC - Overview
Afaxys Pharma LLC - Product / Service
Afaxys Pharma LLC - Key offerings
12.5 Bayer AG
Bayer AG - Overview
Bayer AG - Business segments
Bayer AG - Key news
Bayer AG - Key offerings
Bayer AG - Segment focus
12.6 Combe Inc.
Combe Inc. - Overview
Combe Inc. - Product / Service
Combe Inc. - Key offerings
12.7 Foundation Consumer Healthcare LLC
Foundation Consumer Healthcare LLC - Overview
Foundation Consumer Healthcare LLC - Product / Service
Foundation Consumer Healthcare LLC - Key offerings
12.8 Gedeon Richter Plc
Gedeon Richter Plc - Overview
Gedeon Richter Plc - Business segments
Gedeon Richter Plc - Key offerings
Gedeon Richter Plc - Segment focus
12.9 HLL Lifecare Ltd.
HLL Lifecare Ltd. - Overview
HLL Lifecare Ltd. - Product / Service
HLL Lifecare Ltd. - Key offerings
12.10 Laboratoire HRA Pharma SAS
Laboratoire HRA Pharma SAS - Overview
Laboratoire HRA Pharma SAS - Product / Service
Laboratoire HRA Pharma SAS - Key offerings
12.11 Lupin Ltd.
Lupin Ltd. - Overview
Lupin Ltd. - Product / Service
Lupin Ltd. - Key news
Lupin Ltd. - Key offerings
12.12 Mankind Pharma Ltd.
Mankind Pharma Ltd. - Overview
Mankind Pharma Ltd. - Product / Service
Mankind Pharma Ltd. - Key offerings
12.13 Perrigo Co. Plc
Perrigo Co. Plc - Overview
Perrigo Co. Plc - Business segments
Perrigo Co. Plc - Key offerings
Perrigo Co. Plc - Segment focus
12.14 Pfizer Inc.
Pfizer Inc. - Overview
Pfizer Inc. - Product / Service
Pfizer Inc. - Key news
Pfizer Inc. - Key offerings
12.15 Piramal Enterprises Ltd.
Piramal Enterprises Ltd. - Overview
Piramal Enterprises Ltd. - Product / Service
Piramal Enterprises Ltd. - Key offerings
12.16 Sun Pharmaceutical Industries Ltd.
Sun Pharmaceutical Industries Ltd. - Overview
Sun Pharmaceutical Industries Ltd. - Product / Service
Sun Pharmaceutical Industries Ltd. - Key news
Sun Pharmaceutical Industries Ltd. - Key offerings
12.17 Syzygy Healthcare LLC
Syzygy Healthcare LLC - Overview
Syzygy Healthcare LLC - Product / Service
Syzygy Healthcare LLC - Key offerings
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
13.3 Currency conversion rates for US$
Currency conversion rates for US$
13.4 Research methodology
Research methodology
13.5 Data procurement
Information sources
13.6 Data validation
Data validation
13.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
13.8 Data synthesis
Data synthesis
13.9 360 degree market analysis
360 degree market analysis
13.10 List of abbreviations
List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market by Geography
Exhibits 5: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits 6: Executive Summary - Chart on Market Segmentation by Type
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Company Market Positioning
Exhibits 10: Parent Market
Exhibits 11: Data Table on - Parent Market
Exhibits 12: Market characteristics analysis
Exhibits 13: Value Chain Analysis
Exhibits 14: Offerings of companies included in the market definition
Exhibits 15: Market segments
Exhibits 16: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 17: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 18: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 19: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 20: Historic Market Size - Data Table on Global Emergency Contraceptive Pills Market 2018 - 2022 ($ million)
Exhibits 21: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
Exhibits 22: Historic Market Size - Type Segment 2018 - 2022 ($ million)
Exhibits 23: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits 24: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits 25: Five forces analysis - Comparison between 2023 and 2028
Exhibits 26: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits 27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits 28: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits 29: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits 30: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits 31: Chart on Market condition - Five forces 2023 and 2028
Exhibits 32: Chart on Distribution Channel - Market share 2023-2028 (%)
Exhibits 33: Data Table on Distribution Channel - Market share 2023-2028 (%)
Exhibits 34: Chart on Comparison by Distribution Channel
Exhibits 35: Data Table on Comparison by Distribution Channel
Exhibits 36: Chart on Retail stores - Market size and forecast 2023-2028 ($ million)
Exhibits 37: Data Table on Retail stores - Market size and forecast 2023-2028 ($ million)
Exhibits 38: Chart on Retail stores - Year-over-year growth 2023-2028 (%)
Exhibits 39: Data Table on Retail stores - Year-over-year growth 2023-2028 (%)
Exhibits 40: Chart on Online stores - Market size and forecast 2023-2028 ($ million)
Exhibits 41: Data Table on Online stores - Market size and forecast 2023-2028 ($ million)
Exhibits 42: Chart on Online stores - Year-over-year growth 2023-2028 (%)
Exhibits 43: Data Table on Online stores - Year-over-year growth 2023-2028 (%)
Exhibits 44: Market opportunity by Distribution Channel ($ million)
Exhibits 45: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits 46: Chart on Type - Market share 2023-2028 (%)
Exhibits 47: Data Table on Type - Market share 2023-2028 (%)
Exhibits 48: Chart on Comparison by Type
Exhibits 49: Data Table on Comparison by Type
Exhibits 50: Chart on Combination pills - Market size and forecast 2023-2028 ($ million)
Exhibits 51: Data Table on Combination pills - Market size and forecast 2023-2028 ($ million)
Exhibits 52: Chart on Combination pills - Year-over-year growth 2023-2028 (%)
Exhibits 53: Data Table on Combination pills - Year-over-year growth 2023-2028 (%)
Exhibits 54: Chart on Progesterone pills - Market size and forecast 2023-2028 ($ million)
Exhibits 55: Data Table on Progesterone pills - Market size and forecast 2023-2028 ($ million)
Exhibits 56: Chart on Progesterone pills - Year-over-year growth 2023-2028 (%)
Exhibits 57: Data Table on Progesterone pills - Year-over-year growth 2023-2028 (%)
Exhibits 58: Market opportunity by Type ($ million)
Exhibits 59: Data Table on Market opportunity by Type ($ million)
Exhibits 60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 61: Chart on Market share By Geographical Landscape2023-2028 (%)
Exhibits 62: Data Table on Market share By Geographical Landscape2023-2028 (%)
Exhibits 63: Chart on Geographic comparison
Exhibits 64: Data Table on Geographic comparison
Exhibits 65: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 66: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 67: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits 68: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits 69: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 70: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 71: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 72: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 73: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 74: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 75: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 76: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 77: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 78: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 79: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 80: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 81: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits 82: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits 83: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits 84: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits 85: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits 86: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits 87: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits 88: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits 89: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits 90: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits 91: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 92: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 93: Chart on France - Market size and forecast 2023-2028 ($ million)
Exhibits 94: Data Table on France - Market size and forecast 2023-2028 ($ million)
Exhibits 95: Chart on France - Year-over-year growth 2023-2028 (%)
Exhibits 96: Data Table on France - Year-over-year growth 2023-2028 (%)
Exhibits 97: Chart on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits 98: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits 99: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibits 100: Data Table on Japan - Year-over-year growth 2023-2028 (%)
Exhibits 101: Market opportunity By Geographical Landscape($ million)
Exhibits 102: Data Tables on Market opportunity By Geographical Landscape($ million)
Exhibits 103: Impact of drivers and challenges in 2023 and 2028
Exhibits 104: Overview on criticality of inputs and factors of differentiation
Exhibits 105: Overview on factors of disruption
Exhibits 106: Impact of key risks on business
Exhibits 107: Companies covered
Exhibits 108: Matrix on companies position and classification
Exhibits 109: AbbVie Inc. - Overview
Exhibits 110: AbbVie Inc. - Product / Service
Exhibits 111: AbbVie Inc. - Key news
Exhibits 112: AbbVie Inc. - Key offerings
Exhibits 113: Afaxys Pharma LLC - Overview
Exhibits 114: Afaxys Pharma LLC - Product / Service
Exhibits 115: Afaxys Pharma LLC - Key offerings
Exhibits 116: Bayer AG - Overview
Exhibits 117: Bayer AG - Business segments
Exhibits 118: Bayer AG - Key news
Exhibits 119: Bayer AG - Key offerings
Exhibits 120: Bayer AG - Segment focus
Exhibits 121: Combe Inc. - Overview
Exhibits 122: Combe Inc. - Product / Service
Exhibits 123: Combe Inc. - Key offerings
Exhibits 124: Foundation Consumer Healthcare LLC - Overview
Exhibits 125: Foundation Consumer Healthcare LLC - Product / Service
Exhibits 126: Foundation Consumer Healthcare LLC - Key offerings
Exhibits 127: Gedeon Richter Plc - Overview
Exhibits 128: Gedeon Richter Plc - Business segments
Exhibits 129: Gedeon Richter Plc - Key offerings
Exhibits 130: Gedeon Richter Plc - Segment focus
Exhibits 131: HLL Lifecare Ltd. - Overview
Exhibits 132: HLL Lifecare Ltd. - Product / Service
Exhibits 133: HLL Lifecare Ltd. - Key offerings
Exhibits 134: Laboratoire HRA Pharma SAS - Overview
Exhibits 135: Laboratoire HRA Pharma SAS - Product / Service
Exhibits 136: Laboratoire HRA Pharma SAS - Key offerings
Exhibits 137: Lupin Ltd. - Overview
Exhibits 138: Lupin Ltd. - Product / Service
Exhibits 139: Lupin Ltd. - Key news
Exhibits 140: Lupin Ltd. - Key offerings
Exhibits 141: Mankind Pharma Ltd. - Overview
Exhibits 142: Mankind Pharma Ltd. - Product / Service
Exhibits 143: Mankind Pharma Ltd. - Key offerings
Exhibits 144: Perrigo Co. Plc - Overview
Exhibits 145: Perrigo Co. Plc - Business segments
Exhibits 146: Perrigo Co. Plc - Key offerings
Exhibits 147: Perrigo Co. Plc - Segment focus
Exhibits 148: Pfizer Inc. - Overview
Exhibits 149: Pfizer Inc. - Product / Service
Exhibits 150: Pfizer Inc. - Key news
Exhibits 151: Pfizer Inc. - Key offerings
Exhibits 152: Piramal Enterprises Ltd. - Overview
Exhibits 153: Piramal Enterprises Ltd. - Product / Service
Exhibits 154: Piramal Enterprises Ltd. - Key offerings
Exhibits 155: Sun Pharmaceutical Industries Ltd. - Overview
Exhibits 156: Sun Pharmaceutical Industries Ltd. - Product / Service
Exhibits 157: Sun Pharmaceutical Industries Ltd. - Key news
Exhibits 158: Sun Pharmaceutical Industries Ltd. - Key offerings
Exhibits 159: Syzygy Healthcare LLC - Overview
Exhibits 160: Syzygy Healthcare LLC - Product / Service
Exhibits 161: Syzygy Healthcare LLC - Key offerings
Exhibits 162: Inclusions checklist
Exhibits 163: Exclusions checklist
Exhibits 164: Currency conversion rates for US$
Exhibits 165: Research methodology
Exhibits 166: Information sources
Exhibits 167: Data validation
Exhibits 168: Validation techniques employed for market sizing
Exhibits 169: Data synthesis
Exhibits 170: 360 degree market analysis
Exhibits 171: List of abbreviations

Executive Summary

The following companies are recognized as the key players in the global emergency contraceptive pills market: AbbVie Inc., Afaxys Pharma LLC, Bayer AG, Combe Inc., Foundation Consumer Healthcare LLC, Gedeon Richter Plc, HLL Lifecare Ltd., Knoll Healthcare Pvt. Ltd., Laboratoire HRA Pharma SAS, Lupin Ltd., Mankind Pharma Ltd., Morepen Laboratories Ltd., Perrigo Co. Plc, Pfizer Inc., Piramal Enterprises Ltd., Sun Pharmaceutical Industries Ltd., Syzygy Healthcare LLC, and Teva Pharmaceutical Industries Ltd..

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is importance of family planning."

According to the report, one of the major drivers for this market is the rise in number of initiatives to create awareness.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • AbbVie Inc.
  • Afaxys Pharma LLC
  • Bayer AG
  • Combe Inc.
  • Foundation Consumer Healthcare LLC
  • Gedeon Richter Plc
  • HLL Lifecare Ltd.
  • Knoll Healthcare Pvt. Ltd.
  • Laboratoire HRA Pharma SAS
  • Lupin Ltd.
  • Mankind Pharma Ltd.
  • Morepen Laboratories Ltd.
  • Perrigo Co. Plc
  • Pfizer Inc.
  • Piramal Enterprises Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Syzygy Healthcare LLC
  • Teva Pharmaceutical Industries Ltd.